Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case–control study

PURPOSE: Immune-checkpoint inhibitors (ICI) present a new treatment for malignancies by boosting the immune system. This has led to a variety of immune-related adverse events, including ICI-associated pneumonitis (ICIaP). Diagnosis thereof is often challenging, and its pathogenesis has not yet been...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowalski, Benedikt, Valaperti, Alan, Bezel, Pascal, Steiner, Urs C., Scholtze, Dieter, Wieser, Stephan, Vonow-Eisenring, Maya, Widmer, Andrea, Kohler, Malcolm, Franzen, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189083/
https://www.ncbi.nlm.nih.gov/pubmed/34347128
http://dx.doi.org/10.1007/s00432-021-03750-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189083/
https://www.ncbi.nlm.nih.gov/pubmed/34347128
http://dx.doi.org/10.1007/s00432-021-03750-z

Ejemplares similares